Anco Molijn - Concepedia

Author

Anco Molijn

DDL Diagnostic Laboratory ORCID

Also Known As

A C Molijn, A Molijn, A. Molijn, A.C. Molijn, Anco C Molijn, Anco C. Molijn, Anco Molijn, Wen Chen

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

DDL Diagnostic Laboratory GlaxoSmithKline (Belgium)Erasmus MC Vrije Universiteit Amsterdam Cornell University

About

Anco Molijn is an author at DDL Diagnostic Laboratory specializing in medicine, human papillomavirus vaccines, and cervical cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	28	2.9K
2	Public Health	17	18	1.7K
3	Natural Sciences	4	4	309
4	Health Sciences	1	1	45
5	Biochemistry	1	1	77

Anco Molijn

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus Bernhard Kleter, Leen‐Jan van Doorn, Lianne Schrauwen, Journal of Clinical Microbiology Diagnostic VirologyCancer-associated VirusCervical CancerAnogenital Human PapillomavirusHuman Papillomavirus Vaccines	1999	657
HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases Edyta C. Pirog, Belén Lloveras, Anco Molijn, Modern Pathology	2014	221
Differences in human papillomavirus type distribution in high‐grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe Wiebren Tjalma, Alison Fiander, Olaf Reich, International Journal of Cancer Invasive Cervical CancerPathologyGynecologyCytopathologyCarcinoma	2012	219
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial Nicole J. Polman, Renée M.F. Ebisch, Daniëlle A.M. Heideman, The Lancet Oncology Cervical Cancer ScreeningCervical CancerCervical HealthHuman Papillomavirus VaccinesCancer Screening	2019	214
Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck Walter J. Koskinen, Ren Wei Chen, Ilmo Leivo, International Journal of Cancer PathologyCytopathologyDermatologyOral CancerCancer-associated Virus	2003	201
Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub‐Saharan Africa Lynette Denny, Isaac F. Adewole, Rose Anorlu, International Journal of Cancer	2013	197
One virus, one lesion—individual components of CIN lesions contain a specific HPV type Wim Quint, David Jenkins, Anco Molijn, The Journal of Pathology	2011	196
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study Cosette M. Wheeler, S. Rachel Skinner, Maria Rowena Del Rosario‐Raymundo, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccinologyViviane StudyPrecancerous Lesions	2016	187
Highly Effective Detection of Human Papillomavirus 16 and 18 DNA by a Testing Algorithm Combining Broad-Spectrum and Type-Specific PCR Leen‐Jan van Doorn, Anco Molijn, Bernhard Kleter, Journal of Clinical Microbiology	2006	164
Human papillomavirus prevalence and type‐distribution in cervical glandular neoplasias: Results from a <scp>E</scp>uropean multinational epidemiological study Katsiaryna Holl, Andrzej Nowakowski, Ned Powell, International Journal of Cancer Cervical Glandular NeoplasiasGynecologyPathologyCytopathologyHuman Papillomavirus Prevalence	2015	147

Page 1